Lilly direct-selling Zepbound at $499/mo — compare with 11 other programs

Can I take Wegovy with metformin?

Reviewed by the glpzoom Editorial Team against primary clinical sources — FDA labeling, peer-reviewed trials, and specialty-society guidelines.
Content current as of June 2026; updated when guidance or availability changes.
Yes — Wegovy and metformin are commonly used together, particularly in patients with type 2 diabetes who are also pursuing weight loss. The two medications work through different mechanisms (Wegovy mimics GLP-1; metformin improves insulin sensitivity and reduces hepatic glucose output), so they're additive rather than redundant. Combined use does not significantly increase hypoglycemia risk because neither medication alone causes hypoglycemia in normal patients; risk emerges only when combined with insulin or sulfonylureas. GI side effects can be additive — both medications can cause nausea, diarrhea, and abdominal discomfort. Starting Wegovy while already on metformin (or adding metformin to a stable Wegovy regimen) should be done with close monitoring of GI tolerance. Talk to your prescriber about timing — some patients find taking metformin with food and Wegovy on an empty stomach minimizes overlap.

Where to start

Licensed US telehealth services that handle this. We may earn a commission when you sign up. See disclosure.

  • Ro logo

    Ro

    from $145/mo
    • Best for insured patients
    • Best for clinical oversight

    Ro Body — branded GLP-1 weight care program

  • Hims logo

    Hims

    from $199/mo
    • Best for cash-pay
    • Best for speed

    Hims Weight Loss — compounded GLP-1 from $199/mo

  • Noom Med logo

    Noom Med

    from $179/mo
    • Best for coaching
    • Best for maintenance

    Noom Med — GLP-1 + behavioral psychology coaching

Drugs referenced

Related questions

  • What are the most common Wegovy side effects?

    The most common Wegovy side effects are gastrointestinal: nausea (40-44% of trial patients), diarrhea (30%), vomiting (24%), and constipation (24%). These typically peak during dose escalation in the first 4-8 weeks and improve as the body adapts. Less common but serious risks include gallbladder problems, pancreatitis, kidney strain (especially if dehydrate

We may earn a commission when you click links to partners. Affiliate disclosure.